Manufacturers

Diesse Diagnostica Senese S.p.A.

Via A. Solari, 19 , 20144 Milano
Italy

Telephone +39 0577 319560
Fax +39 0577 318763
salesoffice@diesse.it

Trade fair hall

  • Hall 2 / C17
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 2): stand C17

Fairground map

MEDICA 2016 fairground map: Hall 2

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases

Auto-immune diseases

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases
  • 03.02.03.03  Diagnostics / kits for the thyroid gland analyses (Auto-immune diseases)

Diagnostics / kits for the thyroid gland analyses (Auto-immune diseases)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems

Immuno assay systems

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.06  Enzyme immunoassay (EIA, ELISA, EMIT)

Enzyme immunoassay (EIA, ELISA, EMIT)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry

Rapid tests - Immunochemistry

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03.02.15.02  Infectious disease tests

Infectious disease tests

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.03  Equipment and systems for blood sedimentation

Equipment and systems for blood sedimentation

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.03  Equipment and systems for blood sedimentation
  • 03.03.03.01  Blood sedimentation reading devices

Blood sedimentation reading devices

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.03  Equipment and systems for blood sedimentation
  • 03.03.03.02  Automatic blood sedimentation units

Automatic blood sedimentation units

  • 03  Diagnostics
  • 03.04  Microbiology
  • 03.04.01  Bacteriology

Bacteriology

  • 03  Diagnostics
  • 03.04  Microbiology
  • 03.04.01  Bacteriology
  • 03.04.01.11  Reagents for bacteriology

Reagents for bacteriology

  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.05  Equipment and systems for microbiological diagnosis/virology

Equipment and systems for microbiological diagnosis/virology

  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.05  Equipment and systems for microbiological diagnosis/virology
  • 03.05.05.02  Equipment for microbiological diagnosis

Equipment for microbiological diagnosis

Our products

Product category: Equipment and systems for blood sedimentation, Equipment for microbiological diagnosis

VES Matic Original 20

Automatic instrument for the determination of the ESR on 20 samples simultaneously. The ESR reading at the first hour is performed in 24 minutes including the mixing of samples.

AUTOMATED
Automated system for the direct determination of ESR in 20 samples simultaneously

RESULTS ONLY 20 MINUTES
Results obtained after only 20 minutes of sedimentation

NO INTERFERENCE IN HISTOLOGICAL SAMPLES
It is an excellent system for the ESR in lipemic and bilirubinemic samples

NO BIOLOGICAL RISK
ESR is determined in closed tube:

No contact with blood;
No blood is withdrawn;
No liquid waste is produced.

More Less

About us

Company details

COMPANY PROFILE

DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of innovative clinical systems, with more than 160 highly skilled and qualified employees. DIESSE R&D, Manufacturing and Corporate Marketing departments are located in Siena, Italy. Its Financial Department is located in Milan. DIESSE was founded in 1982, thanks to a partnership between financial investors and top level researchers with long-standing experience in developing clinical diagnostic products and systems.
Throughout its thirty-two year history, DIESSE has focused its efforts on developing a solid position in the market of hematology and infectious disease test systems. In the early years, the company capitalized on its reputation for manufacturing quality and excellent products for serology testing which allowed the company to expand its activities to other strategic markets.
The initial development was greatly assisted by the invention and subsequent patenting of a revolutionary method for the determination of the erythrocyte sedimentation rate (ESR). Based on this technology, DIESSE developed the VESMATIC™ SYSTEM, which reduces the turn-around time of ESR testing by more than fifty percent eliminates the risk of direct exposure to blood samples. Additionally, VESMATIC Systems offer added safety and convenience through the use of non-glass tubes and small sample volume requirements.
Considering product diversification vital for future growth, DIESSE decided to further expand and strengthen its position in other market segments, such as enzyme immunoassay, serology and microbiology. As a result of this strategy, DIESSE introduced SERAMAT, a fully automated system for serological testing which is able to use different analytical methods. SERAMAT was the first automatic instrument to perform complement fixation testing.
In addition, DIESSE developed ROBOBACT, a unique system that allows for the automatic isolation of enteric and urinary pathogens, without opening sample containers.
Furthermore, in 2005 DIESSE introduced two highly innovative systems: CHORUS and. CHORUS is a multi-parametric processor for infectious diseases and autoimmunity using an innovative method of single- test and ready-to-use devices. VESMATIC-CUBE is a fully automated system for ESR testing in standard EDTA tubes; which are normally found with the most common cell counters, already loaded in racks.

The latest addition in the product list is the PlusFinder ++, an automated system for the rapid screening of urinary tract infection by means of the monitoring of the production of CO2 resulting from bacterial metabolism.
All these developments have been the result of steady and solid investment in R & D which allowed DIESSE to develop very efficient production procedures. The innovative technologies associated to this goal, allowed Diesse to be one of the few diagnostic companies involved in the EUREKA Project of the European Community.
DIESSE’s products are sold in more than 60 countries all over the world through mutually beneficial distribution agreements. In addition DIESSE also has OEM supply agreements with some of the largest organizations in the global clinical diagnostics market. Total annual revenue exceeds € 20 million.

 

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 75%

Number of employees

100-499

Foundation

1982

Area of business

Diagnostics